회사 소개
- 법인명: Viwit Pharmaceutical Co., Ltd.
- 국제 명칭: 维威制药 (Viwit Pharmaceutical Co., Ltd.), China
- 브랜드명 / 상호: Viwit
- 등록 국가: China
설명:
Viwit Pharmaceutical Co., Ltd., established in 2006, manufactures pharmaceutical intermediates and active pharmaceutical ingredients with a particular specialization in borane- and boron-based reducing reagents, including borane-dimethyl sulfide, borane-THF, borane-pyridine, and various borane-amine complexes, alongside chiral pyrrolidine, piperidine, and indanyl building blocks. Its finished API portfolio includes aprepitant and fosaprepitant dimeglumine, varenicline tartrate, luliconazole, vildagliptin, and the MRI contrast agents gadobutrol monohydrate and gadolinium meglumine. The company offers CRO, CMO, and CDMO contract manufacturing under OEM, ODM, and own-brand arrangements, and sells across North America, Central/South America, Western and Eastern Europe, Australasia, Asia, the Middle East, and Africa.
사업 활동
건강기능식품 & 뉴트라슈티컬
공급업체
완제 의약품
제조업체
바이오의약품
생명공학/바이오제약 기업
원료의약품(API)
제조업체
제약용 화학물질
제조업체
ATC 분류체계 (해부치료화학분류)
제조업체
판매 시장
- Western Europe: Austria, Belgium, France
- Northern America: Bermuda, Canada, Greenland, Saint Pierre and Miquelon, United States
- Central America: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama
- South America: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, Falkland Islands, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela
주요 제품/서비스
- 원료의약품(API): Gadobutrol monohydrate, Aprepitant, Lifitegrast, Varenicline Tartrate, EFINACONAZOLE, Fosaprepitant dimeglumine, Gadolinium meglumine, Luliconazole, Miraberon
- 계약 및 아웃소싱 서비스: Product Development
- 완제 의약품: Finished antibiotic medicines
- 제약용 화학물질: (+)-B-Chlorodiisopinocampheylborane, Catecholborane, (R)-(+)-2-(Diphenylhydroxymethyl)pyrrolidine, (S)-(-)-2-(Diphenylhydroxymethyl)pyrrolidine, Borane tetrahydrofuran complex, (R)-(5-Cyano-2, 3-dihydro-1H-inden-1-yl) carbamic acid tert-butyl ester, (R)-tert-Butyl (5-bromo-2, 3-dihydro-1H-inden-1-yl) carbamate(R)-TERT-BUTYL (5-BROMO-2,3-DIHYDRO-1H-INDEN-1-YL)CARBAMATE, (R)-1-Amino -2, 3-dihydro-1H-indene-5-carbonitrile hydrochloride, 1-Methyl-6-boronic acid pinacolyl ester-3,4-dihydroquinoline -2(1H)-one, (1S,2S,3R,5S)-(+)-2,3-Pinanediol, 1-(2-Tetrahydropyranyl)-1H-pyrazole-5-boronic acid ester, 1-(((2R,3S)-2-(2,4-difluorophenyl)-3-methylepoxyethyl-2-yl) methyl)-1H-1,2,4-triazole, 1-BOC-3, 3-Dimethyl-4-oxopiperidine, 1-HYDROXYETHYL ADAMANTANE, [1,1 '-Biphenyl]-4-yl [4-[[1,1'-biphenyl]-4-sulfanyl] phenyl] thioninium-tetrakis (pentafluorophenyl) borate, 1,1-Dimethylethyl 4-hydroxy-4-[(2-methoxyethoxy)methyl]-1-piperidinecarboxylate, 1,2-Bis [(trifluorovinyl) oxy] ethane, 1H-indazole -7-carboxylic acid methyl ester, 1H-indazole-7-carboxamide, (1R,2R,3S,5R)-(-)-2,3-Pinanediol, 2 - methyl -5-- nitroimidazole, 2 '-fluoro -1,1': 4 ', 1'-terphenyl, 2-((1R)-1-AMINOETHYL)-4-FLUOROPHENOL, 2-(2-Amino-5-bromo-benzoyl) pyridine, 2-Chloro-1, 3,2-dioxaphosphine, 2-Chloro-3-fluorophenylboronic acid, 2-Fluoro-6-hydroxyphenylboronic acid pinacol ester, ((2-Fluoro-8-(4,4, 5,5-tetramethyl -1,3, 2-dioxaborolan-2-yl) naphthalen-1-yl) ethynyl) triisopropylsilane, 2-Methylpyridine-N-borane, (2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1, 2,4-triazol-1-yl) butane-2, 3-diol, (2R,3S)-2-[(1R)-1-[3,5-bis (trifluoromethyl) phenyl] ethoxy]-3-(4-fluorophenyl)-morpholine hydrochloride(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride, (2R,3S)-2-[(1R)-1-[3,5-bis (trifluoromethyl) phenyl] ethoxy]-3-(4-fluorophenyl) morpholine p-benzenesulfonate, (3-(9-borabicyclo[3.3.1]nonan-9-yl)propyl)triphenylphosphoniumebromide, 3-acetamidopyrazole, 3-Chloro-5-hydroxybenzonitrile, 3-Fluoro-5-hydroxybenzonitrile, 3-fluoroquinoline -5-borate pinacol ester, 3,5-Difluorobenzonitrile, 4-Bromo-2-fluorobiphenyl, 4-Cyano -1-(2,6-difluorobenzyl)-1H-1,2,3-triazole, 4-Methanesulfonyl-cyclohexyl ketone, 4-Methylene Piperidine Hydrochloride, 5-Bromo-3-fluoroquinoline, 5-chloromethyl-2, 4-dihydro [1,2,4] triazol-3-one, 5-ethyl -2-methyl pyridine borane, 6-Bromo-3-iodo-1-methyl-1H-indazole, 6,6-Dimethyl-3-azabicyclo [3.1.0] hexane-2, 4-dione, 6,6-Dimethyl-3-azabicyclo [3.1.0] hexane, 7-Carboxyl -1H-indazole, 7-Hydroxy-[1,2,4] triazolo [1,5-A] pyridine, 9-Borabicyclo[3.3.1]nonane, Borane-2-picoline complex, Borane-ammonia, borane diethylamine complex, Borane-dimethyl sulfide complex intermediates, Borane-dimethylamine, Borane-N,N-diisopropylethylamine, Borane-pyridine, Borane-tert-butylamine complex, borane triethylamine complex, borane trimethylamine complex, cis-1-BOC-3, 4-dihydroxypyrrolidine, Cis-1-BOC-3-hydroxy-4-methoxypyrrolidine, cis-1-BOC-pyrrolidine-3, 4-diamine, cis-3, 4-dihydroxypyrrolidine hydrochloride, Decafluoro-3-methoxy-2-trifluoromethylpentane, Diethyl (3-Pyridyl) Borane, DOTA intermediates, ethyl 2-acetyl acetate chloride, Ethyl 3-(2-chlorophenoxy)-2-butenoate, FOMC-Glutamic acid -5-methyl ester, Glyoxal -1,1-dimethyl acetal, imidazole -1-yl acetonitrile, Indolo [2,3-A] carbazole, Methyl (3S)-7-bromo-2, 3-dihydro-2-oxo-5-(2-pyridyl)-1H-1, 4-benzodiazepine -3-propionate, Methylboronic acid, N-BOC-Amino-piperidinyl -1,1-carboxylic acid, N-Methyl morpholine borane, N-tert-butyl-1H-indazole-7-carboxamide, N,N-Diethylaniline Borane intermediates, N,N-dihexadecylphenylammonium tetrakis (pentafluorophenyl) borateN,N-dihexadecylanilinium tetrakis(pentafluorophenyl)borate, N,N-Dimethylanilinium tetrakis (pentafluorophenyl) borate, N,N-dioctadecylmethylammonium tetrakis(pentafluorophenyl)borate, Pinacolborane intermediates, Potassium tetrakis (pentafluorophenyl) borate, Propylgallate Injection, Pyridine-2-sulfonyl fluoride, (R)-( )-1-Phenylethanol, (R)-3-(Methoxymethyl) pyrrolidine -1-carboxylic acid ((3S,7aS)-7a-hydroxymethyl-6-(methylene) tetrahydro1H-pyrrorizin-3-yl) methanol ester, (R)-Methyl Oxazaborolidine intermediates, (S)-(-)-1-Phenylethanol, (S)-(-)-1,2, 3,4-tetrahydro-1-naphthoic acid, (S)-2-Amino-5-methoxytetrahydronaphthalene (S)-mandelate, (S)-2-Chloro-1-(2,4-dichlorophenyl), (S)-2-Chloro-1-(2,4-dichlorophenyl) ethyl methanesulfonate, (S)-3-Amino -3-(4-chlorophenyl)-propionic acid, (S)-Methyl Oxazaborolidine intermediates, Sodium tetrakis (pentafluorophenyl) borate, tert-Butyl 1-oxo-6-azospiro [2.5] octane -6-carboxylate, tert-Butyl 2-((4R,6R)-6-(2-(4-fluorophenyl)-4-((4-(hydroxymethyl) phenyl) carbamoyl)-5-isopropyl-3-phenyl-1H-pyrrol-1-yl) ethyl)-2,2-dimethyl-1,3-diox-4-yl) acetate, tert-Butyl 3,3-dimethyl -4-(((trifluoromethyl) sulfonyl) oxy)-3,6-dihydropyridine -1(2H)-carboxylatetert-Butyl 3,3-dimethyl-4-(((trifluoromethyl)sulfonyl)oxy)-3,6-dihydropyridine-1(2H)-carboxylate, tert-Butyl (3S)-3-(4-bromophenyl) piperidine-1-carboxylatetert-butyl (S)-3-(4-bromophenyl)piperidine-1-carboxylate, tert-Butyl trans-(3R,4R)-3,4-diaminopyrrolidine-1-carboxylate, tert-Butyl trans-(3S,4S)-3,4-diaminopyrrolidine-1-carboxylate, Tetrabenzyl pyrophosphate, Triethylboron -1,3-propanediamine, Triethylboron -1,6-hexanediamine, Trimethylboroxine, Triphenylcarbon tetrakis (pentafluorophenyl) borate
- ATC 분류체계 (해부치료화학분류): Vildagliptin, Aceglutamide Injection
당사 제품 & 서비스
Sell · Pharma Chemicals
Sell · Laboratory Chemicals, Solvents & Reference Standards
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Pharma Chemicals
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · Active Pharmaceutical Ingredients (APIs)
Sell · ATC (Anatomical Therapeutic Chemical) Classification
인증
평점
(0)
(0)
(0)
(0)
(0)
댓글
필터:
정렬:
댓글이 없습니다.
평가 & 댓글 남기기